Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medtronic plc Proxy Solicitation & Information Statement 2019

Oct 24, 2019

29841_rns_2019-10-24_22cf94e3-5e54-444f-bf3f-ab34078a78fc.zip

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

DEFA14A 1 lmdt2019_defa14a.htm MEDTRONIC PLC - DEFA14A html PUBLIC "-//W3C//DTD HTML 4.0//EN" MEDTRONIC PLC - DEFA 14A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the Securities

Exchange Act of 1934 (Amendment No. )

Filed by the Registrant Filed by a Party other than the Registrant

Check the appropriate box:
Preliminary Proxy Statement
CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material Pursuant to §240.14a-12

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

| Payment
of Filing Fee (Check the appropriate box): | |
| --- | --- |
| ● | No fee required. |
| ● | Fee computed on table below per Exchange Act
Rules 14a-6(i)(4) and 0-11. |
| | (1) Title of each class of securities to which
transaction applies: |
| | (2) Aggregate number of securities to which
transaction applies: |
| | (3) Per
unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which
the filing fee is calculated and state how it was determined): |
| | (4) Proposed maximum aggregate value of transaction: |
| | (5) Total fee paid: |
| ● | Fee paid previously with preliminary materials. |
| ● | Check box if any part of the fee is offset as
provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify
the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
| | (1) Amount Previously Paid: |
| | (2) Form, Schedule or Registration Statement No.: |
| | (3) Filing Party: |
| | (4) Date Filed: |

* Exercise Your Right to Vote ***

Important Notice Regarding the Availability of Proxy Materials for the Shareholder Meeting to Be Held on December 6, 2019.

MEDTRONIC PLC

MEDTRONIC PLC ATTN: MARCY CAMAROTTO 710 MEDTRONIC PARKWAY MS LC300 MINNEAPOLIS, MN 55432-5604

Meeting Information
Meeting Type: Annual General Meeting
For holders as of: October 10, 2019
Date: December 6, 2019 Time: 8:00 AM Local Time
Location: Shelbourne Hotel
27 St. Stephen’s Green
Dublin, Ireland
You are receiving this communication because you hold shares in the company named above.
This is not a ballot. You cannot use this notice to vote these
shares. This communication presents only an overview of the more complete proxy materials that are available to you on the
Internet. You may view the proxy materials online at www.proxyvote.com, scan the QR Barcode on the reverse side, or
easily request a paper copy (see reverse side).
We encourage you to access and review all of the important information contained in the proxy materials before voting.
See the reverse side of this notice to obtain proxy materials and voting instructions.
Before You Vote
How to Access the Proxy Materials
Proxy Materials Available to VIEW or RECEIVE:
PROXY STATEMENT ANNUAL REPORT
How to View Online:
Have the information that is printed
in the box marked by the arrow (located on the
following page) and visit: www.proxyvote.com, or scan the QR Barcode below.
How to Request and Receive a PAPER or E-MAIL Copy:
If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:
1) BY INTERNET : www.proxyvote.com
2) BY TELEPHONE : 1-800-579-1639
3) BY E-MAIL *: [email protected]
* If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow (located on the following page) in the subject line.
Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before November 22, 2019 to facilitate timely delivery.
How To Vote
Please Choose One of the Following Voting Methods

| Vote In Person: Many shareholder
meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the
entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the
meeting, you will need to request a ballot to vote these shares. |
| --- |
| Vote By Internet: Go to www.proxyvote.com or from a smartphone, scan the QR Barcode above. Have the information that is printed in the box
marked by the arrow (located on the following
page) available and follow the instructions. |
| Vote By Mail: You can vote
by mail by requesting a paper copy of the materials, which will include a proxy card. |
| Shareholder Meeting Registration: To vote and/or attend the meeting, go to the “Register for Meeting” link at www.proxyvote.com. |

Voting Items
The Board of Directors recommends you vote FOR
the following proposals:
1.
Nominees:
1a. Richard H. Anderson
1b. Craig Arnold
1c. Scott C. Donnelly
1d. Andrea J. Goldsmith, Ph.D.
1e. Randall J. Hogan, III
1f. Omar Ishrak
1g. Michael O. Leavitt
1h. James T. Lenehan
1i. Geoffrey S. Martha
1j. Elizabeth G. Nabel, M.D.
1k. Denise M. O’Leary
1l. Kendall J. Powell

| 2. | To ratify, in a non-binding vote, the appointment of
PricewaterhouseCoopers LLP as Medtronic’s independent
auditor for fiscal year 2020 and to authorize, in a binding
vote, the Board of Directors, acting through the Audit
Committee, to set the auditor’s remuneration. |
| --- | --- |
| 3. | To approve, in a non-binding advisory vote, named
executive officer compensation (a “Say-on-Pay” vote). |
| 4. | To renew the Board’s authority to issue shares. |
| 5. | To renew the Board’s authority to opt out of pre-emption
rights. |
| 6. | Authorizing the Company and any subsidiary of the
Company to make overseas market purchases of
Medtronic ordinary shares. |
| 7. | Transacting any other business that may properly come
before the meeting. |